Overview

Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Provide patients with serious AdV infection or disease access to treatment with BCV.
Details
Lead Sponsor:
Chimerix
Treatments:
Brincidofovir